O	0	3	Can
B-intervention	4	11	Dietary
I-intervention	12	15	and
I-intervention	16	24	Physical
I-intervention	25	33	Activity
O	34	47	Modifications
O	48	54	Reduce
B-condition	55	61	Breast
I-condition	62	69	Density
O	70	72	in
O	73	87	Postmenopausal
O	88	93	Women
O	93	94	?

O	95	98	The
O	99	103	DAMA
O	104	109	Study
O	109	110	,
O	111	112	a
O	113	123	Randomized
O	124	136	Intervention
O	137	142	Trial
O	143	145	in
O	146	151	Italy
O	151	152	.

O	153	156	Few
O	157	167	randomized
O	168	174	trials
O	175	179	have
O	180	184	been
O	185	192	carried
O	193	196	out
O	197	199	to
O	200	208	evaluate
O	209	212	the
O	213	219	effect
O	220	222	of
O	223	232	lifestyle
O	233	246	modifications
O	247	249	on
O	250	262	mammographic
O	263	269	breast
O	270	277	density
O	278	279	(
O	279	282	MBD
O	282	283	)
O	283	284	.

O	285	288	The
O	289	299	randomized
O	300	301	2
O	302	303	Ã—
O	304	305	2
O	306	315	factorial
O	316	320	Diet
O	320	321	,
O	322	330	physical
O	331	339	Activity
O	340	343	and
O	344	355	MAmmography
O	356	361	trial
O	362	367	aimed
O	368	370	to
O	371	379	evaluate
O	380	387	whether
O	388	391	MBD
O	392	395	can
O	396	398	be
O	399	406	reduced
O	407	409	in
O	410	424	postmenopausal
O	425	430	women
O	431	435	with
O	436	440	high
O	441	449	baseline
O	450	453	MBD
O	454	456	by
O	457	458	a
O	459	461	24
O	461	462	-
O	462	467	month
O	468	475	dietary
O	476	479	and
O	479	480	/
O	480	482	or
O	483	491	physical
O	492	500	activity
O	501	502	(
O	502	504	PA
O	504	505	)
O	506	519	interventions
O	519	520	.

O	521	523	We
O	524	534	randomized
B-eligibility	535	542	healthy
I-eligibility	543	557	postmenopausal
I-eligibility	558	563	women
O	563	564	,
O	565	574	attending
O	575	578	the
B-location	579	587	Florence
I-location	588	589	(
I-location	589	594	Italy
I-location	594	595	)
O	596	608	mammographic
O	609	618	screening
O	619	626	program
O	626	627	,
O	628	632	ages
B-age	633	635	50
I-age	636	638	to
I-age	639	641	69
I-age	642	647	years
O	647	648	,
B-eligibility	649	659	nonsmokers
I-eligibility	659	660	,
I-eligibility	661	665	with
I-eligibility	666	669	MBD
I-eligibility	670	671	>
I-eligibility	672	674	50
I-eligibility	674	675	%
I-eligibility	676	679	and
I-eligibility	680	682	no
I-eligibility	683	689	recent
I-eligibility	690	697	hormone
I-eligibility	698	705	therapy
O	705	706	,
O	707	709	to
O	710	711	(
O	711	712	i
O	712	713	)
O	714	715	a
O	716	723	dietary
O	724	736	intervention
O	737	744	focused
O	745	747	on
O	748	753	plant
O	754	759	foods
O	759	760	,
O	761	765	with
O	766	767	a
O	768	771	low
O	772	780	glycemic
O	781	785	load
O	785	786	,
O	787	790	low
O	791	793	in
O	794	803	saturated
O	804	808	fats
O	809	812	and
O	813	820	alcohol
O	820	821	;
O	822	823	(
O	823	825	ii
O	825	826	)
O	827	828	a
O	829	831	PA
O	832	844	intervention
O	845	854	combining
O	855	860	daily
O	861	869	moderate
O	870	879	intensity
O	880	890	activities
O	891	894	and
O	895	898	one
O	899	905	weekly
O	906	916	supervised
O	917	924	session
O	925	927	of
O	928	932	more
O	933	942	strenuous
O	943	951	activity
O	951	952	;
O	953	954	(
O	954	957	iii
O	957	958	)
O	959	963	both
O	964	977	interventions
O	977	978	;
O	979	980	(
O	980	982	iv
O	982	983	)
B-control	984	991	general
I-control	992	1007	recommendations
O	1007	1008	.

O	1009	1011	We
O	1012	1021	evaluated
O	1022	1029	changes
O	1030	1032	in
O	1033	1036	MBD
O	1037	1042	based
O	1043	1045	on
O	1046	1053	Volpara
O	1054	1063	estimates
O	1064	1073	comparing
O	1074	1082	baseline
O	1083	1086	and
O	1087	1093	follow
O	1093	1094	-
O	1094	1096	up
O	1097	1104	digital
O	1105	1115	mammograms
O	1116	1118	by
O	1119	1121	an
O	1122	1131	intention
O	1131	1132	-
O	1132	1134	to
O	1134	1135	-
O	1135	1140	treat
O	1140	1141	-
O	1141	1149	analysis
O	1149	1150	.

O	1151	1154	MBD
O	1155	1163	measures
O	1164	1168	were
O	1169	1178	available
O	1179	1182	for
B-total-participants	1183	1186	226
O	1187	1199	participants
O	1199	1200	.

O	1201	1203	An
O	1204	1215	interaction
O	1216	1223	emerged
O	1224	1231	between
O	1232	1242	treatments
O	1243	1246	and
O	1247	1251	thus
O	1252	1254	we
O	1255	1258	run
O	1259	1267	analyses
O	1268	1270	by
O	1271	1275	arms
O	1275	1276	.

O	1277	1278	A
O	1279	1287	decrease
O	1288	1290	in
B-outcome	1291	1301	volumetric
I-outcome	1302	1309	percent
I-outcome	1310	1317	density
O	1318	1325	emerged
O	1326	1329	for
O	1330	1335	women
O	1336	1338	in
O	1339	1342	the
O	1343	1350	dietary
O	1351	1363	intervention
O	1364	1365	(
O	1365	1370	ratio
O	1371	1372	0
O	1372	1373	.
O	1373	1375	91
O	1375	1376	;
O	1377	1379	95
O	1379	1380	%
O	1381	1383	CI
O	1383	1384	,
O	1385	1386	0
O	1386	1387	.
O	1387	1389	86
O	1389	1390	-
O	1390	1391	0
O	1391	1392	.
O	1392	1394	97
O	1394	1395	;
O	1396	1397	P
O	1398	1399	=
O	1400	1401	0
O	1401	1402	.
O	1402	1405	002
O	1405	1406	)
O	1407	1410	and
O	1411	1413	in
O	1414	1417	the
O	1418	1420	PA
O	1421	1433	intervention
O	1434	1437	arm
O	1438	1439	(
O	1439	1440	0
O	1440	1441	.
O	1441	1443	93
O	1443	1444	;
O	1445	1447	95
O	1447	1448	%
O	1449	1451	CI
O	1451	1452	,
O	1453	1454	0
O	1454	1455	.
O	1455	1457	87
O	1457	1458	-
O	1458	1459	0
O	1459	1460	.
O	1460	1462	98
O	1462	1463	;
O	1464	1465	P
O	1466	1467	=
O	1468	1469	0
O	1469	1470	.
O	1470	1472	01
O	1472	1473	)
O	1474	1476	in
O	1477	1487	comparison
O	1488	1492	with
O	1493	1501	controls
O	1501	1502	.

O	1503	1505	No
O	1506	1511	clear
O	1512	1518	effect
O	1519	1526	emerged
O	1527	1529	in
O	1530	1533	the
O	1534	1540	double
O	1541	1553	intervention
O	1554	1557	arm
O	1557	1558	.

O	1559	1563	This
O	1564	1576	intervention
O	1577	1582	trial
O	1583	1591	suggests
O	1592	1596	that
O	1597	1598	a
O	1599	1601	24
O	1601	1602	-
O	1602	1607	month
O	1608	1615	dietary
O	1616	1618	or
O	1619	1621	PA
O	1622	1634	intervention
O	1635	1638	may
O	1639	1645	reduce
B-outcome	1646	1649	MBD
O	1650	1652	in
O	1653	1667	postmenopausal
O	1668	1673	women
O	1673	1674	.

O	1675	1676	A
O	1677	1689	modification
O	1690	1692	of
O	1693	1700	dietary
O	1701	1707	habits
O	1708	1710	or
O	1711	1713	an
O	1714	1722	increase
O	1723	1725	in
O	1726	1728	PA
O	1729	1731	in
O	1732	1746	postmenopausal
O	1747	1752	women
O	1753	1756	may
O	1757	1763	reduce
B-outcome	1764	1767	MBD
O	1767	1768	.

O	1769	1776	Further
O	1777	1784	studies
O	1785	1788	are
O	1789	1795	needed
O	1796	1798	to
O	1799	1806	confirm
O	1807	1812	these
O	1813	1821	findings
O	1822	1825	for
O	1826	1834	planning
O	1835	1841	breast
O	1842	1848	cancer
O	1849	1859	preventive
O	1860	1870	strategies
O	1870	1871	.
